ZURA (STOCKS)
Zura Bio Limited Class A Ordinary Shares
$5.570000
-0.060000 (-1.07%)
Prev close: $5.630000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Sandeep C. Kulkarni
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $534.73M
- Employees
- 30
- P/E (TTM)
- -4.43
- P/B (TTM)
- 2.80
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
7
Strong Buy
6
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.22 | $-0.18 | -0.0425 | -23.94% |
|
Dec 2025 (Q4)
|
$-0.49 | $-0.20 | -0.2896 | -144.51% |
|
Sep 2025 (Q3)
|
$-0.21 | $-0.19 | -0.0249 | -13.45% |
|
Jun 2025 (Q2)
|
$-0.17 | $-0.19 | +0.0221 | +11.50% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $6.93M |
| Operating Expenses | $92.75M |
| Research and Development | $58.36M |
| Other Operating Expenses | $34.39M |
| Operating Income/Loss | -$92.75M |
| Income/Loss From Continuing Operations After Tax | -$85.74M |
| Income/Loss From Continuing Operations Before Tax | -$85.82M |
| Net Income/Loss | -$35.27M |
| Net Income/Loss Attributable To Noncontrolling Interest | $50.48M |
| Net Income/Loss Attributable To Parent | -$85.74M |
| Net Income/Loss Available To Common Stockholders, Basic | -$116.45M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $30.70M |
| Preferred Stock Dividends And Other Adjustments | $30.70M |
| Basic Earnings Per Share | -$1.12 |
| Diluted Earnings Per Share | -$1.12 |
| Basic Average Shares | 214,336,754 |
| Diluted Average Shares | 214,336,754 |
| Assets | $213.40M |
| Current Assets | $210.50M |
| Noncurrent Assets | $2.90M |
| Fixed Assets | $149.00K |
| Other Non-current Assets | $2.75M |
| Liabilities | $16.32M |
| Current Liabilities | $16.32M |
| Accounts Payable | $3.28M |
| Other Current Liabilities | $13.04M |
| Noncurrent Liabilities | $0.00 |
| Equity | $197.09M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $197.09M |
| Temporary Equity | $0.00 |
| Liabilities And Equity | $213.40M |
| Net Cash Flow From Operating Activities | -$64.83M |
| Net Cash Flow From Operating Activities, Continuing | -$64.83M |
| Net Cash Flow From Investing Activities | -$112.97K |
| Net Cash Flow From Investing Activities, Continuing | -$112.97K |
| Net Cash Flow From Financing Activities | -$2.03M |
| Net Cash Flow From Financing Activities, Continuing | -$2.03M |
| Net Cash Flow | -$66.97M |
| Net Cash Flow, Continuing | -$66.97M |
| Comprehensive Income/Loss | -$35.27M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$35.27M |
| Other Comprehensive Income/Loss | $0.00 |